Ramucirumab with cisplatin and fluoropyrimidine as first-line therapy in patients with metastatic gastric or junctional adenocarcinoma (RAINFALL): a double-blind, randomised, placebo-controlled, phase 3 trial.
The Lancet Oncology.
Times cited: 14
Risk factors for gastrointestinal stromal tumor recurrence in patients treated with adjuvant imatinib.
Times cited: 39